HI STEM GGMBH has a total of 16 patent applications. It increased the IP activity by 600.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are SHEKDAR KAMBIZ, COLLEGE MEDICINE POCHON CHA UNIV IND ACAD COOP FOUND and NAT CENTER FOR CHILD HEALTH AND DEVELOPMENT.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Canada | 4 | |
#4 | EPO (European Patent Office) | 1 | |
#5 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Therapeutic chemical compounds | |
#5 | Analysing materials | |
#6 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Trumpp Andreas | 15 |
#2 | Sprick Martin Ronald | 8 |
#3 | Eisen Christian Thomas | 7 |
#4 | Raffel Simon | 4 |
#5 | Falcone Mattia | 4 |
#6 | Edenhofer Frank | 2 |
#7 | Thier Marc | 2 |
#8 | Hommerding Oliver | 2 |
#9 | Kaschutnig Paul | 1 |
#10 | Christian Thomas Eisen | 1 |
Publication | Filing date | Title |
---|---|---|
CA3067447A1 | Novel methods for the generation and use of human induced neural border stem cells | |
US2019382851A1 | Novel methods for sub-typing and treating cancer | |
WO2018037091A1 | Methods for the identification and isolation of hematopoietic stem and progenitor cells | |
WO2016045799A1 | Novel methods for sub-typing and treating cancer | |
WO2014056627A1 | Novel approaches for individualized therapy of pancreatic ductal adenocarcinoma | |
CA2887920A1 | Novel biomarkers for sub-typing pancreatic ductal adenocarcinoma |